Honglei Chen

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Venues

International journal of molecular sciences

Clinical drug investigation

Tissue barriers

Cancer research

Rush Medical College of Rush University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rush Medical College of Rush University May 01 2012 - Jul 31 2013

United States

Postdoc :: Biochemistry

Publications

Weiqian Zhang, Ke Xu, Zhengfa Li, Linwei Wang, Honglei Chen
Tumor immune microenvironment components and the other markers can predict the efficacy of neoadjuvant chemotherapy for breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Xuehan Chen, Yanzhuo Liu, Yang Wang, Chenlong Wang, Xuewei Chen, Yu Xiong, Lilong Liu, Xi Yuan, Honglin Tang, Chong Shu, Jing Zhang, Austin M Guo, Honglei Chen, Jing Yang
CYP4F2-Catalyzed Metabolism of Arachidonic Acid Promotes Stromal Cell-Mediated Immunosuppression in Non-Small Cell Lung Cancer. Cancer research 82 (21) (2022)
Yue Xi, Tiange Zhang, Wei Sun, Ruobing Liang, Sridha Ganesh, Honglei Chen
GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis. International journal of molecular sciences 23 (23) (2022)
Yue Xi, Tiange Zhang, Wei Sun, Ruobing Liang, Sridha Ganesh, Honglei Chen
GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis. International journal of molecular sciences 23 (23) (2022)
Yue Xi, Tiange Zhang, Wei Sun, Ruobing Liang, Sridha Ganesh, Honglei Chen
GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis. International journal of molecular sciences 23 (23) (2022)
Long Long, Li Zhang, Yuhan Yang, Yunfeng Zhou, Honglei Chen
Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinoma. Immunotherapy 14 (6) (2022)
Yue Xi, Tiange Zhang, Wei Sun, Ruobing Liang, Sridha Ganesh, Honglei Chen
GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis. International journal of molecular sciences 23 (23) (2022)
Yue Xi, Tiange Zhang, Wei Sun, Ruobing Liang, Sridha Ganesh, Honglei Chen
GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis. International journal of molecular sciences 23 (23) (2022)
Kanwal Raghav, Suyu Liu, Michael James Overman, Anneleis F Willett, Mark Knafl, Szu-Chin Fu, Anais Malpica, Seema Prasad, Richard E Royal, Christopher P Scally, Paul F Mansfield, Ignacio I Wistuba, Andrew P Futreal, Dipen Maheshbhai Maru, Luisa M Solis Soto, Edwin R Parra Cuentas, Honglei Chen, Pamela Villalobos, Anuj Verma, Armeen Mahvash, Patrick Hwu, Patricia Cortazar, Edward McKenna, Cindy Yun, Shannon Dervin, Katja Schulze, Walter C Darbonne, Ajaykumar C Morani, Scott Kopetz, Keith F Fournier, Scott E Woodman, James C Yao, Gauri R Varadhachary, Daniel M Halperin
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma. Cancer discovery 11 (11) (2021)
Yu Yuan, Abdalla Adam, Chen Zhao, Honglei Chen
Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy. Cancers 13 (4) (2021)
Yuyang Zeng, Mengxi Chen, Sridha Ganesh, Shunze Hu, Honglei Chen
Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer. PloS one 15 (5) (2020)
Long Long, Chen Zhao, Muqimova Ozarina, Xianda Zhao, Jing Yang, Honglei Chen
Targeting Immune Checkpoints in Lung Cancer: Current Landscape and Future Prospects. Clinical drug investigation 39 (4) (2019)
Honglei Chen, Rong Lu, Yong-Guo Zhang, Jun Sun
Vitamin D Receptor Deletion Leads to the Destruction of Tight and Adherens Junctions in Lungs. Tissue barriers 6 (4) (2018)

Honglei Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Honglei Chen